Arsène MEKINIAN
Assistance Publique - Hôpitaux de Paris · Internal Medecine_Hospital Saint Antoine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Arsène MEKINIAN as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:17 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04791280 · Study of the Intestinal Microbiota of Patients With Systemic SclerosisAssistance Publique - Hôpitaux de Paris · unknown · Systemic Sclerosis · principal investigator
- Ph2NCT04275778 · HYDROxychloroquine in Syndrome Primary AntiPhospholipidAssistance Publique - Hôpitaux de Paris · withdrawn · Antiphospholipid Syndrome in Pregnancy, Anticoagulants · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:17 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.Ann Rheum Dis · 2019333 citationsRCR 12.6
- Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study.Ann Rheum Dis · 2016124 citationsRCR 6.2
- 113 citationsRCR 5.3
- 94 citationsRCR 6.6
- Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.Ann Rheum Dis · 202191 citationsRCR 6.9
- Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study.Rheumatology (Oxford) · 201269 citationsRCR 2.4
- Pneumocystis jirovecii colonization in patients with systemic autoimmune diseases: prevalence, risk factors of colonization and outcome.Rheumatology (Oxford) · 201138 citationsRCR 1.3
- Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome.NEJM Evid · 202437 citationsRCR 9.5
- [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].Gynecol Obstet Fertil Senol · 201826 citationsRCR 1.4
- Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial.Ann Intern Med · 202524 citationsRCR 8.0